3176.TWO · MEDIGEN
Taiwan · RS rating 81 · As of 2026-10-08
| Price | 38.70 TWD |
|---|---|
| 1-day change | +0.9% |
| RS rating (overall / 1M / 3M / 12M) | 81 / 84 / 65 / 74 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 56 / 56 / 77 |
| Industry group (rank) | Medical-Biomed/Biotech (53) |
| EPS growth Q/Q | +50.0% |
| Sales growth Q/Q | +8.9% |
| Distance from 52-week high | +3.0% |
| Market cap (USD) | $163.8M |